Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study
Clinical trial NCT05180851 · UNKNOWN
Trial details
- NCT number
- NCT05180851
- Sponsor
- Shanghai Fengxian District Central Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2023-05-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.